Effect of BI 1181181 on Midazolam, Warfarin, Omeprazole and Digoxin
Status:
Withdrawn
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
To assess the influence of different dose strengths of BI 1181181 on single dose kinetics of
midazolam (CYP3A4 probe drug), warfarin (CYP2C9 probe drug), omeprazole (CYP2C19 probe drug)
and digoxin (P-gp probe drug)